Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Income Statements (unaudited)

v3.22.1
Condensed Consolidated Income Statements (unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues:    
Total revenues $ 22,438,538 $ 17,547,965
Cost of revenues:    
Total cost of revenues 2,312,771 1,765,317
Selling and marketing expenses 3,287,488 2,489,279
Depreciation and amortization 1,629,176 1,169,866
General and administrative expenses 15,378,623 10,087,060
Total selling, general and administrative expenses 20,295,287 13,746,205
Net loss on disposition or impairment 6,906 64,767
(Loss) income from operations (176,426) 1,971,676
Other expense, net (16,147) (21,537)
(Loss) income before income tax benefit (192,573) 1,950,139
Income tax expense (benefit) 13,224 (364,148)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total $ (205,797) $ 2,314,287
Earnings per share:    
Basic earnings per share (in dollars per share) $ (0.01) $ 0.16
Diluted earnings per share (in dollars per share) $ (0.01) $ 0.16
Basic weighted average shares (in shares) 14,432,652 14,178,542
Diluted weighted average shares (in shares) 14,432,652 14,854,809
Revenues from company-owned or managed clinics    
Revenues:    
Total revenues $ 12,606,999 $ 9,466,083
Royalty fees    
Revenues:    
Total revenues 6,008,932 4,769,246
Franchise fees/Franchise and regional development cost of revenues    
Revenues:    
Total revenues 640,965 695,427
Cost of revenues:    
Cost of revenues 2,002,813 1,624,572
Advertising fund revenue    
Revenues:    
Total revenues 1,710,717 1,374,741
Software fees/IT cost of revenues    
Revenues:    
Total revenues 956,998 760,537
Cost of revenues:    
Cost of revenues 309,958 140,745
Regional developer fees    
Revenues:    
Total revenues 201,787 217,956
Other revenues    
Revenues:    
Total revenues $ 312,140 $ 263,975